{
  "name": "MedCap",
  "slug": "medcap",
  "description": "Statiskt källarkiv med kurshistorik, finansiella rapporter och regulatoriska dokument. För nordiska bolag används Nasdaq Nordic primärt och MFN endast för saknade rapportperioder.",
  "status": "complete",
  "updated_at": "2026-08-06T01:48:39Z",
  "nasdaq_status": "retrieved",
  "latest_market": "2026-08-05: stängning 538.00, volym 14120",
  "mfn_status": "retrieved",
  "mfn_count": 2,
  "nasdaq_reports_status": "retrieved",
  "reports": {
    "available": true,
    "url": "/company/medcap/reports",
    "count": 13,
    "nasdaq_count": 11,
    "mfn_fallback_count": 2,
    "items": [
      {
        "report_key": "2026:q2",
        "period_label": "2026 Q2",
        "date": "2026-07-21",
        "title": "Kvartalsrapport Q2 2026",
        "original_title": "Stark tillväxt; justerad EBITA ökade med 28 %",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b7e43cd7f772daa0e9b41919f1c584916&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2026,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2026",
            "title": "Kvartalsrapport Q2 2026",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/af2c519957a42a36007c5b1718ce608e8",
            "date": "2026-07-21",
            "period": "2026-q2",
            "form_type": "interim-report",
            "report_key": "2026:q2",
            "filename": "MedCap_Delarsrapport_Q2_2026.pdf",
            "text_chars": 60799,
            "sha256": "ab03765f6cdfdbe18a32c5baf2e8cc8608db384f7768c9e4d25e27cb33642b34",
            "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
            "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
            "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2026/part-001.html",
                "chars": 60799
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2026:q1",
        "period_label": "2026 Q1",
        "date": "2026-04-29",
        "title": "Kvartalsrapport Q1 2026",
        "original_title": "Strong result; EBITA increased by 30%",
        "category": "Interim report (Q1 and Q3)",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b138f37863a3825a8c89c4d1687b8f1a3&lang=en&src=listed",
        "language": "en",
        "report_type": "interim-report",
        "fiscal_year": 2026,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
            "title": "Kvartalsrapport Q1 2026",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a50705ec3320edf2fb04c04840b83a2c0",
            "date": "2026-04-29",
            "period": "2026-q1",
            "form_type": "interim-report",
            "report_key": "2026:q1",
            "filename": "MedCap_Interim_Report_Q1_2026.pdf",
            "text_chars": 44476,
            "sha256": "25f1bfcb5a71347a61c3ae71766dd125054a28c85092d0f69c1dda348186c92b",
            "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
            "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
            "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
                "chars": 44476
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:annual",
        "period_label": "2025 Årsredovisning",
        "date": "2026-03-23",
        "title": "Årsredovisning 2025",
        "original_title": "MedCap publicerar årsredovisning för 2025",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bf904a02082b3e5a25ad32ea81ed00f3a&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2025,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2025",
            "title": "Årsredovisning 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a8ca69fe4fa09117cf1c6713077fc3912",
            "date": "2026-03-23",
            "period": "2025-annual",
            "form_type": "annual-report",
            "report_key": "2025:annual",
            "filename": "MedCap_AR_2025_Publ.pdf",
            "text_chars": 249298,
            "sha256": "f2bd84670da8648236d87979680b5c774956527f4652ebc65ac3ffefd4d3d773",
            "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2025",
            "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-arsredovisning-2025",
            "txt_url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
                "chars": 178094
              },
              {
                "number": 2,
                "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
                "chars": 71202
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q4",
        "period_label": "2025 Q4",
        "date": "2026-02-06",
        "title": "Kvartalsrapport Q4 2025",
        "original_title": "Starkt resultat; EBITA ökade med 68% i kvartalet och 26% för helåret",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bf8f99e5eb9020b3d8594f9ea69f0af32&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2025,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
            "title": "Kvartalsrapport Q4 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/ad01d76a40184d357e30ac2879601ca0e",
            "date": "2026-02-06",
            "period": "2025-q4",
            "form_type": "year-end-report",
            "report_key": "2025:q4",
            "filename": "MedCap_Bokslutskommunike_2025.pdf",
            "text_chars": 61274,
            "sha256": "9b6ba6520539e52e68acfb7b660f86481d09bdebf0f5b371d8b95fb48bd5c890",
            "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
            "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
            "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
                "chars": 61274
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q3",
        "period_label": "2025 Q3",
        "date": "2025-10-24",
        "title": "Kvartalsrapport Q3 2025",
        "original_title": "Strong organic and acquired growth; EBITA increased by 32%",
        "category": "interim-report",
        "source": "MFN fallback",
        "source_class": "mfn",
        "source_url": "https://mfn.se/cis/a/medcap/strong-organic-and-acquired-growth-ebita-increased-by-32-8f9a71cb",
        "language": "unknown",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "mfn-fallback-kvartalsrapport-q3-2025",
            "title": "Kvartalsrapport Q3 2025",
            "source": "MFN fallback",
            "source_class": "mfn",
            "source_url": "https://mb.cision.com/Main/2678/4255245/3742455.pdf",
            "date": "2025-10-24",
            "period": "2025-q3",
            "form_type": "interim-report",
            "report_key": "2025:q3",
            "filename": "3742455.pdf",
            "text_chars": 62500,
            "sha256": "0c9bdbb9e12e0e7292955290ac9a7e69802f015fe65e3f559b2fda13c680c739",
            "url": "/company/medcap/documents/mfn-fallback-kvartalsrapport-q3-2025",
            "absolute_url": "https://spela.port0.org/company/medcap/documents/mfn-fallback-kvartalsrapport-q3-2025",
            "txt_url": "/company/medcap/documents/mfn-fallback-kvartalsrapport-q3-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/mfn-fallback-kvartalsrapport-q3-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/medcap/documents/mfn-fallback-kvartalsrapport-q3-2025/part-001.html",
                "chars": 62500
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q2",
        "period_label": "2025 Q2",
        "date": "2025-07-23",
        "title": "Kvartalsrapport Q2 2025",
        "original_title": "Starkt kvartal med 20 procent EBITA tillväxt samt förvärv inom Specialistläkemedel",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=ba5a9182794fde0269a6bed1f4b614545&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
            "title": "Kvartalsrapport Q2 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a7af8e7db35101c836d373b8c0484f1f1",
            "date": "2025-07-23",
            "period": "2025-q2",
            "form_type": "interim-report",
            "report_key": "2025:q2",
            "filename": "07222486.pdf",
            "text_chars": 55690,
            "sha256": "bcaa54d585ec09a492db4eada70b3c520bbd2b021c7b490a5144286d48e7c793",
            "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
            "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
            "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
                "chars": 55690
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q1",
        "period_label": "2025 Q1",
        "date": "2025-04-29",
        "title": "Kvartalsrapport Q1 2025",
        "original_title": "7% tillväxt och EBITA marginalen återställd till 17%",
        "category": "interim-report",
        "source": "MFN fallback",
        "source_class": "mfn",
        "source_url": "https://mfn.se/cis/a/medcap/7-tillvaxt-och-ebita-marginalen-aterstalld-till-17-2bf0a741",
        "language": "unknown",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "mfn-fallback-kvartalsrapport-q1-2025",
            "title": "Kvartalsrapport Q1 2025",
            "source": "MFN fallback",
            "source_class": "mfn",
            "source_url": "https://mb.cision.com/Main/2678/4141406/3415977.pdf",
            "date": "2025-04-29",
            "period": "2025-q1",
            "form_type": "interim-report",
            "report_key": "2025:q1",
            "filename": "3415977.pdf",
            "text_chars": 45278,
            "sha256": "0ac60857aaaa88e1159e6fdcdf3fea9f15d756add1aa0ad74717717301604157",
            "url": "/company/medcap/documents/mfn-fallback-kvartalsrapport-q1-2025",
            "absolute_url": "https://spela.port0.org/company/medcap/documents/mfn-fallback-kvartalsrapport-q1-2025",
            "txt_url": "/company/medcap/documents/mfn-fallback-kvartalsrapport-q1-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/mfn-fallback-kvartalsrapport-q1-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/medcap/documents/mfn-fallback-kvartalsrapport-q1-2025/part-001.html",
                "chars": 45278
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:annual",
        "period_label": "2024 Årsredovisning",
        "date": "2025-03-27",
        "title": "Årsredovisning 2024",
        "original_title": "MedCap publicerar årsredovisning för 2024",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b764c63f79bc4dcc98248251f5d5cd384&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2024,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2024",
            "title": "Årsredovisning 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a2beca6f0d9a6de70e60697594735f60f",
            "date": "2025-03-27",
            "period": "2024-annual",
            "form_type": "annual-report",
            "report_key": "2024:annual",
            "filename": "03244505.pdf",
            "text_chars": 247971,
            "sha256": "54c058ede8e895953a467dfd18f6902555363db590889a0cddbf5a56a3b52004",
            "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2024",
            "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-arsredovisning-2024",
            "txt_url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
                "chars": 179928
              },
              {
                "number": 2,
                "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
                "chars": 68041
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q4",
        "period_label": "2024 Q4",
        "date": "2025-01-31",
        "title": "Kvartalsrapport Q4 2024",
        "original_title": "God efterfrågan men otillfredsställande resultat. Starkt kassaflöde.",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b70c90fa68fd37056cf3479f7efc9c21c&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2024,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
            "title": "Kvartalsrapport Q4 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a7f6fac26e24857539f6bf4f631864936",
            "date": "2025-01-31",
            "period": "2024-q4",
            "form_type": "year-end-report",
            "report_key": "2024:q4",
            "filename": "01309848.pdf",
            "text_chars": 57835,
            "sha256": "afe8a1a2e27a73119b4a4d896ff81590499d2ee8d7f2a1449636a39fdcd792d0",
            "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
            "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
            "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
                "chars": 57835
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q2",
        "period_label": "2024 Q2",
        "date": "2024-07-24",
        "title": "Kvartalsrapport Q2 2024",
        "original_title": "Fortsatt stark tillväxt - justerad EBITA ökade 13 procent",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b352b617c9d71ae801979224548b6e20c&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
            "title": "Kvartalsrapport Q2 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a12fc6d98326123a3834970f31dd37722",
            "date": "2024-07-24",
            "period": "2024-q2",
            "form_type": "interim-report",
            "report_key": "2024:q2",
            "filename": "07238540.pdf",
            "text_chars": 50069,
            "sha256": "944a3a385cee620edd040ccd8c93c2625ce12df3977643bb1dabb547dd6b41da",
            "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
            "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
            "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
                "chars": 50069
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:annual",
        "period_label": "2023 Årsredovisning",
        "date": "2024-03-27",
        "title": "Årsredovisning 2023",
        "original_title": "MedCap publicerar årsredovisning för 2023",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b95122d4eba19666b8fc0710d8450de73&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2023,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2023",
            "title": "Årsredovisning 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/af17915e95d886a8a01ad9ce93a5e913d",
            "date": "2024-03-27",
            "period": "2023-annual",
            "form_type": "annual-report",
            "report_key": "2023:annual",
            "filename": "03263053.pdf",
            "text_chars": 234714,
            "sha256": "c1cd2d5aa82b1e34fdb4cc200bb881951e60c682ec229afbfb209ace84486c87",
            "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2023",
            "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-arsredovisning-2023",
            "txt_url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
                "chars": 179088
              },
              {
                "number": 2,
                "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
                "chars": 55624
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q4",
        "period_label": "2023 Q4",
        "date": "2024-01-31",
        "title": "Kvartalsrapport Q4 2023",
        "original_title": "Fortsatt stark tillväxt i kvartalet - EBITDA ökade 42 procent",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=ba6b1802cc7fe491c76f050ec018f34e1&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2023,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
            "title": "Kvartalsrapport Q4 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a3b17ee25e1c6dea88b2fdb94709359e2",
            "date": "2024-01-31",
            "period": "2023-q4",
            "form_type": "year-end-report",
            "report_key": "2023:q4",
            "filename": "01308987.pdf",
            "text_chars": 55355,
            "sha256": "e6997a595be3d1068f9137e2ea94854094a1bee6a3b26203af09a3799833be30",
            "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
            "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
            "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
                "chars": 55355
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q2",
        "period_label": "2023 Q2",
        "date": "2023-07-28",
        "title": "Kvartalsrapport Q2 2023",
        "original_title": "Fortsatt stark tillväxt - EBITDA ökade 46 procent",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=ba454bde73471c13e67234643d8715c72&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
            "title": "Kvartalsrapport Q2 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a4ce579eaa927bfa5774c44744e354f32",
            "date": "2023-07-28",
            "period": "2023-q2",
            "form_type": "interim-report",
            "report_key": "2023:q2",
            "filename": "07279201.pdf",
            "text_chars": 48451,
            "sha256": "d08bb8782e3f98c6576672e89d751a48c74207488897e4561ed4045a5c7b941f",
            "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
            "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
            "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
                "chars": 48451
              }
            ]
          }
        ],
        "alternatives": []
      }
    ]
  },
  "report_count": 13,
  "nasdaq_report_count": 11,
  "mfn_fallback_count": 2,
  "sec_status": "skipped",
  "sec_count": 0,
  "fi_status": "retrieved",
  "fi_summary": {
    "company": "MedCap",
    "identity": {
      "issuer": "MedCap AB (publ)",
      "lei": "549300NGO5XAJ6TL8719",
      "source": "FI aggregerade blankningspositioner",
      "row_count": 60,
      "score": 118.0,
      "status": "resolved",
      "requested_company": "MedCap",
      "query": "MedCap AB (publ)",
      "candidate_count": 346
    },
    "period": {
      "from": "2024-08-04",
      "to": "2026-08-04",
      "years": 2
    },
    "generated_at": "2026-08-04T14:21:09Z",
    "insider": {
      "transactions": 59,
      "all_export_rows": 59,
      "acquisitions": 25,
      "disposals": 20,
      "other": 14,
      "acquisition_value_sek": 3460292.6,
      "disposal_value_sek": 87322863.0,
      "characters": {
        "Avyttring": 20,
        "Förvärv": 25,
        "Lösen minskning": 7,
        "Lösen ökning": 7
      }
    },
    "short_selling": {
      "aggregate_percent": 0.51,
      "current_public_positions": 0,
      "historical_changes": 0,
      "current_position_sum_over_0_5": 0
    },
    "sources": {
      "insider_register": "https://www.fi.se/sv/vara-register/insynsregistret/",
      "short_register": "https://www.fi.se/sv/vara-register/blankningsregistret/"
    }
  },
  "warnings": [],
  "source_identity": {
    "nasdaq_reports": {
      "slug": "mcap",
      "instrument_id": "TX195548",
      "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/mcap?id=TX195548"
    },
    "mfn": {
      "status": "resolved",
      "company_name": "MedCap",
      "expected_name": "MedCap",
      "match_score": 100.0,
      "slug": "medcap",
      "url": "https://mfn.se/all/a/medcap",
      "metadata": {
        "country": "Sverige",
        "list": "Mid Cap Stockholm",
        "sector": "Hälsovård",
        "industry": "Medicinteknik",
        "website": "https://mb.cision.com/Main/2678/4255245/3742455.pdf"
      },
      "ticker_candidates": [],
      "attempts": []
    },
    "sec": null,
    "nasdaq": {
      "instrument_id": "TX195548",
      "asset_class": "SHARES",
      "isin": "SE0009160872",
      "symbol": "MCAP",
      "company": "MedCap",
      "market": null,
      "last_sale_price": "SEK 538.00",
      "time_as_of": "2026-08-05"
    },
    "finansinspektionen": {
      "issuer": "MedCap AB (publ)",
      "lei": "549300NGO5XAJ6TL8719",
      "source": "FI aggregerade blankningspositioner",
      "row_count": 60,
      "score": 118.0,
      "status": "resolved",
      "requested_company": "MedCap",
      "query": "MedCap AB (publ)",
      "candidate_count": 346
    }
  },
  "documents": [
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2026",
      "title": "Kvartalsrapport Q2 2026",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/af2c519957a42a36007c5b1718ce608e8",
      "date": "2026-07-21",
      "period": "2026-q2",
      "form_type": "interim-report",
      "report_key": "2026:q2",
      "filename": "MedCap_Delarsrapport_Q2_2026.pdf",
      "text_chars": 60799,
      "sha256": "ab03765f6cdfdbe18a32c5baf2e8cc8608db384f7768c9e4d25e27cb33642b34",
      "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
      "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
      "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2026/part-001.html",
          "chars": 60799
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
      "title": "Kvartalsrapport Q1 2026",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a50705ec3320edf2fb04c04840b83a2c0",
      "date": "2026-04-29",
      "period": "2026-q1",
      "form_type": "interim-report",
      "report_key": "2026:q1",
      "filename": "MedCap_Interim_Report_Q1_2026.pdf",
      "text_chars": 44476,
      "sha256": "25f1bfcb5a71347a61c3ae71766dd125054a28c85092d0f69c1dda348186c92b",
      "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
      "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
      "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
          "chars": 44476
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2025",
      "title": "Årsredovisning 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a8ca69fe4fa09117cf1c6713077fc3912",
      "date": "2026-03-23",
      "period": "2025-annual",
      "form_type": "annual-report",
      "report_key": "2025:annual",
      "filename": "MedCap_AR_2025_Publ.pdf",
      "text_chars": 249298,
      "sha256": "f2bd84670da8648236d87979680b5c774956527f4652ebc65ac3ffefd4d3d773",
      "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2025",
      "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-arsredovisning-2025",
      "txt_url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
          "chars": 178094
        },
        {
          "number": 2,
          "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
          "chars": 71202
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
      "title": "Kvartalsrapport Q4 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/ad01d76a40184d357e30ac2879601ca0e",
      "date": "2026-02-06",
      "period": "2025-q4",
      "form_type": "year-end-report",
      "report_key": "2025:q4",
      "filename": "MedCap_Bokslutskommunike_2025.pdf",
      "text_chars": 61274,
      "sha256": "9b6ba6520539e52e68acfb7b660f86481d09bdebf0f5b371d8b95fb48bd5c890",
      "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
      "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
      "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
          "chars": 61274
        }
      ]
    },
    {
      "doc_id": "mfn-fallback-kvartalsrapport-q3-2025",
      "title": "Kvartalsrapport Q3 2025",
      "source": "MFN fallback",
      "source_class": "mfn",
      "source_url": "https://mb.cision.com/Main/2678/4255245/3742455.pdf",
      "date": "2025-10-24",
      "period": "2025-q3",
      "form_type": "interim-report",
      "report_key": "2025:q3",
      "filename": "3742455.pdf",
      "text_chars": 62500,
      "sha256": "0c9bdbb9e12e0e7292955290ac9a7e69802f015fe65e3f559b2fda13c680c739",
      "url": "/company/medcap/documents/mfn-fallback-kvartalsrapport-q3-2025",
      "absolute_url": "https://spela.port0.org/company/medcap/documents/mfn-fallback-kvartalsrapport-q3-2025",
      "txt_url": "/company/medcap/documents/mfn-fallback-kvartalsrapport-q3-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/mfn-fallback-kvartalsrapport-q3-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/medcap/documents/mfn-fallback-kvartalsrapport-q3-2025/part-001.html",
          "chars": 62500
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
      "title": "Kvartalsrapport Q2 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a7af8e7db35101c836d373b8c0484f1f1",
      "date": "2025-07-23",
      "period": "2025-q2",
      "form_type": "interim-report",
      "report_key": "2025:q2",
      "filename": "07222486.pdf",
      "text_chars": 55690,
      "sha256": "bcaa54d585ec09a492db4eada70b3c520bbd2b021c7b490a5144286d48e7c793",
      "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
      "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
      "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
          "chars": 55690
        }
      ]
    },
    {
      "doc_id": "mfn-fallback-kvartalsrapport-q1-2025",
      "title": "Kvartalsrapport Q1 2025",
      "source": "MFN fallback",
      "source_class": "mfn",
      "source_url": "https://mb.cision.com/Main/2678/4141406/3415977.pdf",
      "date": "2025-04-29",
      "period": "2025-q1",
      "form_type": "interim-report",
      "report_key": "2025:q1",
      "filename": "3415977.pdf",
      "text_chars": 45278,
      "sha256": "0ac60857aaaa88e1159e6fdcdf3fea9f15d756add1aa0ad74717717301604157",
      "url": "/company/medcap/documents/mfn-fallback-kvartalsrapport-q1-2025",
      "absolute_url": "https://spela.port0.org/company/medcap/documents/mfn-fallback-kvartalsrapport-q1-2025",
      "txt_url": "/company/medcap/documents/mfn-fallback-kvartalsrapport-q1-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/mfn-fallback-kvartalsrapport-q1-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/medcap/documents/mfn-fallback-kvartalsrapport-q1-2025/part-001.html",
          "chars": 45278
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2024",
      "title": "Årsredovisning 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a2beca6f0d9a6de70e60697594735f60f",
      "date": "2025-03-27",
      "period": "2024-annual",
      "form_type": "annual-report",
      "report_key": "2024:annual",
      "filename": "03244505.pdf",
      "text_chars": 247971,
      "sha256": "54c058ede8e895953a467dfd18f6902555363db590889a0cddbf5a56a3b52004",
      "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2024",
      "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-arsredovisning-2024",
      "txt_url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
          "chars": 179928
        },
        {
          "number": 2,
          "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
          "chars": 68041
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
      "title": "Kvartalsrapport Q4 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a7f6fac26e24857539f6bf4f631864936",
      "date": "2025-01-31",
      "period": "2024-q4",
      "form_type": "year-end-report",
      "report_key": "2024:q4",
      "filename": "01309848.pdf",
      "text_chars": 57835,
      "sha256": "afe8a1a2e27a73119b4a4d896ff81590499d2ee8d7f2a1449636a39fdcd792d0",
      "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
      "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
      "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
          "chars": 57835
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
      "title": "Kvartalsrapport Q2 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a12fc6d98326123a3834970f31dd37722",
      "date": "2024-07-24",
      "period": "2024-q2",
      "form_type": "interim-report",
      "report_key": "2024:q2",
      "filename": "07238540.pdf",
      "text_chars": 50069,
      "sha256": "944a3a385cee620edd040ccd8c93c2625ce12df3977643bb1dabb547dd6b41da",
      "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
      "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
      "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
          "chars": 50069
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2023",
      "title": "Årsredovisning 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/af17915e95d886a8a01ad9ce93a5e913d",
      "date": "2024-03-27",
      "period": "2023-annual",
      "form_type": "annual-report",
      "report_key": "2023:annual",
      "filename": "03263053.pdf",
      "text_chars": 234714,
      "sha256": "c1cd2d5aa82b1e34fdb4cc200bb881951e60c682ec229afbfb209ace84486c87",
      "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2023",
      "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-arsredovisning-2023",
      "txt_url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
          "chars": 179088
        },
        {
          "number": 2,
          "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
          "chars": 55624
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
      "title": "Kvartalsrapport Q4 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a3b17ee25e1c6dea88b2fdb94709359e2",
      "date": "2024-01-31",
      "period": "2023-q4",
      "form_type": "year-end-report",
      "report_key": "2023:q4",
      "filename": "01308987.pdf",
      "text_chars": 55355,
      "sha256": "e6997a595be3d1068f9137e2ea94854094a1bee6a3b26203af09a3799833be30",
      "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
      "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
      "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
          "chars": 55355
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
      "title": "Kvartalsrapport Q2 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a4ce579eaa927bfa5774c44744e354f32",
      "date": "2023-07-28",
      "period": "2023-q2",
      "form_type": "interim-report",
      "report_key": "2023:q2",
      "filename": "07279201.pdf",
      "text_chars": 48451,
      "sha256": "d08bb8782e3f98c6576672e89d751a48c74207488897e4561ed4045a5c7b941f",
      "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
      "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
      "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
          "chars": 48451
        }
      ]
    },
    {
      "doc_id": "mfn-mfn-bolagssida-och-bolagsmetadata",
      "title": "MFN bolagssida och bolagsmetadata",
      "source": "MFN",
      "source_class": "mfn",
      "source_url": "https://mfn.se/all/a/medcap",
      "date": null,
      "period": null,
      "form_type": "company-page",
      "report_key": null,
      "filename": "company.txt",
      "text_chars": 13532,
      "sha256": "5045fffb1c4aff309ffb819d8e6c8a809a3eb0341da225f00cde8e7a57436525",
      "url": "/company/medcap/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
      "absolute_url": "https://spela.port0.org/company/medcap/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
      "txt_url": "/company/medcap/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/medcap/documents/mfn-mfn-bolagssida-och-bolagsmetadata/part-001.html",
          "chars": 13532
        }
      ]
    }
  ],
  "market_files": [
    {
      "label": "Nasdaq kurshistorik CSV",
      "url": "/company/medcap/market/history.csv",
      "absolute_url": "https://spela.port0.org/company/medcap/market/history.csv"
    },
    {
      "label": "Nasdaq kurshistorik JSON",
      "url": "/company/medcap/market/history.json",
      "absolute_url": "https://spela.port0.org/company/medcap/market/history.json"
    },
    {
      "label": "Nasdaq manifest JSON",
      "url": "/company/medcap/market/manifest.json",
      "absolute_url": "https://spela.port0.org/company/medcap/market/manifest.json"
    },
    {
      "label": "Nasdaq instrumentidentitet JSON",
      "url": "/company/medcap/market/instrument.json",
      "absolute_url": "https://spela.port0.org/company/medcap/market/instrument.json"
    },
    {
      "label": "SEC sammanfattning JSON",
      "url": "/company/medcap/market/sec-summary.json",
      "absolute_url": "https://spela.port0.org/company/medcap/market/sec-summary.json"
    },
    {
      "label": "MFN manifest JSON",
      "url": "/company/medcap/market/mfn-manifest.json",
      "absolute_url": "https://spela.port0.org/company/medcap/market/mfn-manifest.json"
    },
    {
      "label": "Nasdaq rapportmanifest JSON",
      "url": "/company/medcap/market/nasdaq-reports-manifest.json",
      "absolute_url": "https://spela.port0.org/company/medcap/market/nasdaq-reports-manifest.json"
    }
  ],
  "sec_facts": {
    "status": "missing",
    "metrics": []
  },
  "morningstar": {
    "configured": true,
    "status": "retrieved",
    "captured_at": "2026-08-01T03:08:20Z",
    "view_count": 4,
    "url": "/company/medcap/morningstar",
    "path": "D:\\Web\\aktieanalys\\public\\company\\.medcap.tmp\\morningstar",
    "files": [
      "index.html",
      "summary.txt",
      "screenshot.png"
    ]
  },
  "finansinspektionen": {
    "available": true,
    "status": "retrieved",
    "url": "/company/medcap/finansinspektionen",
    "transaction_count": 59,
    "aggregate_short_percent": 0.51,
    "files": [
      {
        "filename": "summary.json",
        "label": "Sammanfattning JSON",
        "url": "summary.json"
      },
      {
        "filename": "insider-transactions.csv",
        "label": "Insynstransaktioner CSV",
        "url": "insider-transactions.csv"
      },
      {
        "filename": "insider-transactions.json",
        "label": "Insynstransaktioner JSON",
        "url": "insider-transactions.json"
      },
      {
        "filename": "short-current.json",
        "label": "Aktuella blankningspositioner JSON",
        "url": "short-current.json"
      },
      {
        "filename": "short-history.json",
        "label": "Historiska blankningspositioner JSON",
        "url": "short-history.json"
      },
      {
        "filename": "short-aggregate.json",
        "label": "Aggregerad blankning JSON",
        "url": "short-aggregate.json"
      },
      {
        "filename": "manifest.json",
        "label": "Hämtningsmanifest JSON",
        "url": "manifest.json"
      }
    ]
  },
  "llms_url": "/company/medcap/llms.txt",
  "json_url": "/company/medcap/company.json",
  "document_index_url": "/company/medcap/documents.json",
  "absolute_url": "https://spela.port0.org/company/medcap"
}